The European medicinal agency has reviewed Halamid for fin fish use and concluded no MRL was necessary (Annex II); in the United States the FDA is reviewing Halamid and given it the so-called MUMS status in 2006. This status allows use of products with pending registration on species that are not a major food source. In the United States Halamid has a full NADA status as an aquaculture drug by the FDA since May 2014.